Human Genome Epidemiology Literature Finder
|
Records 1 - 25 (of 25 Records) |
| Query Trace: Astrocytoma and MGMT[original query] |
|---|
| Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
| MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. Journal of neuro-oncology 2011 Feb 101 (3): 405-17. Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N |
| First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response. Neuro-oncology 2011 Feb 13 (2): 235-41. Taal Walter, Dubbink Hendrikus J, Zonnenberg Chris B L, Zonnenberg Bernard A, Postma Tjeerd J, Gijtenbeek Johanna M M, Boogerd Willem, Groenendijk Floris H, Kros Johan M, Kouwenhoven Mathilde C M, van Marion Ronald, van Heuvel Irene, van der Holt Bronno, Bromberg Jacoline E C, Sillevis Smitt Peter A E, Dinjens Winand N M, van den Bent Martin J, |
| Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta neuropathologica 2010 Dec 120 (6): 707-18. Hartmann Christian, Hentschel Bettina, Wick Wolfgang, Capper David, Felsberg Jörg, Simon Matthias, Westphal Manfred, Schackert Gabriele, Meyermann Richard, Pietsch Torsten, Reifenberger Guido, Weller Michael, Loeffler Markus, von Deimling Andre |
| Molecular markers in low-grade gliomas: predictive or prognostic? Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
| Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
| IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy. Journal of neuro-oncology 2014 Jun 118 (2): 377-83. Minniti Giuseppe, Scaringi Claudia, Arcella Antonella, Lanzetta Gaetano, Di Stefano Domenica, Scarpino Stefania, Bozzao Alessandro, Pace Andrea, Villani Veronica, Salvati Maurizio, Esposito Vincenzo, Giangaspero Felice, Enrici Riccardo Mauri |
| ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients. Histology and histopathology 2015 Sep 11664. Shao Li-Wei, Pan Yi, Qi Xue-Ling, Li Yong-Xiao, Ma Xiao-Long, Yi Wei-Ning, Zhang Jing, Zhong Yan-Feng, Chang Qi |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene. Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
| Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
| [IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy]. Zhonghua bing li xue za zhi Chinese journal of pathology 2014 Oct 43 (10): 668-72. Jiang Mengwan, Dong Xianghui, Li Jiayao, Li Jingqi, Qi Jipi |
| Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
| The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta neuropathologica communications 2017 Aug 5 (1): 62. Lee Yujin, Koh Jaemoon, Kim Seong-Ik, Won Jae Kyung, Park Chul-Kee, Choi Seung Hong, Park Sung-H |
| Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Acta neurochirurgica 2018 9 160 (11): 2237-2248. Hong Bujung, Banan Rouzbeh, Christians Arne, Nakamura Makoto, Lalk Michael, Lehmann Ulrich, Hartmann Christian, Krauss Joachim |
| Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas. Oncology letters 2018 2 15 (2): 1600-1606. Sippl Christoph, Urbschat Steffi, Kim Yoo Jin, Senger Sebastian, Oertel Joachim, Ketter Ra |
| Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
| Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma. Cellular and molecular neurobiology 2020 Jun . Carlos-Escalante José Alberto, Gómez-Flores-Ramos Liliana, Bian Xiaopeng, Perdomo-Pantoja Alexander, de Andrade Kelvin César, Mejía-Pérez Sonia Iliana, Cacho-Díaz Bernardo, González-Barrios Rodrigo, Reynoso-Noverón Nancy, Soto-Reyes Ernesto, Sánchez-Correa Thalía Estefanía, Guerra-Calderas Lissania, Yan Chunhua, Chen Qingrong, Castro-Hernández Clementina, Vidal-Millán Silvia, Taja-Chayeb Lucía, Gutiérrez Olga, Álvarez-Gómez Rosa María, Gómez-Amador Juan Luis, Ostrosky-Wegman Patricia, Mohar-Betancourt Alejandro, Herrera-Montalvo Luis Alonso, Corona Teresa, Meerzaman Daoud, Wegman-Ostrosky Tal |
| Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis. Acta neuropathologica 2020 11 141 (1): 85-100. Suwala Abigail K, Stichel Damian, Schrimpf Daniel, Kloor Matthias, Wefers Annika K, Reinhardt Annekathrin, Maas Sybren L N, Kratz Christian P, Schweizer Leonille, Hasselblatt Martin, Snuderl Matija, Abedalthagafi Malak Sameer J, Abdullaev Zied, Monoranu Camelia M, Bergmann Markus, Pekrun Arnulf, Freyschlag Christian, Aronica Eleonora, Kramm Christof M, Hinz Felix, Sievers Philipp, Korshunov Andrey, Kool Marcel, Pfister Stefan M, Sturm Dominik, Jones David T W, Wick Wolfgang, Unterberg Andreas, Hartmann Christian, Dodgshun Andrew, Tabori Uri, Wesseling Pieter, Sahm Felix, von Deimling Andreas, Reuss David |
| Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II. Scientific reports 2020 11 10 (1): 19758. Karschnia Philipp, Teske Nico, Dorostkar Mario M, Siller Sebastian, Weller Jonathan, Baehring Joachim M, Dietrich Jorg, von Baumgarten Louisa, Herms Jochen, Tonn Joerg-Christian, Thon Nikl |
| Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma. Future science OA 2021 2 7 (3): FSO663. Pandith Arshad A, Qasim Iqbal, Baba Shahid M, Koul Aabid, Zahoor Wani, Afroze Dil, Lateef Adil, Manzoor Usma, Bhat Ina A, Sanadhya Dheera, Bhat Abdul R, Ramzan Altaf U, Mohammad Fozia, Anwar Iq |
| TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
| Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review. European journal of cancer (Oxford, England : 1990) 2022 9 175 214-223. Tesileanu C Mircea S, Vallentgoed Wies R, French Pim J, van den Bent Martin |
| H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis. World neurosurgery 2022 6 165 e251-e264. Bin-Alamer Othman, Jimenez Adrian E, Azad Tej D, Bettegowda Chetan, Mukherjee Debr |
| Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker. Journal of neuro-oncology 2022 12 161 (1): 165-174. Carlos-Escalante José Alberto, Mejía-Pérez Sonia Iliana, Soto-Reyes Ernesto, Guerra-Calderas Lissania, Cacho-Díaz Bernardo, Torres-Arciga Karla, Montalvo-Casimiro Michel, González-Barrios Rodrigo, Reynoso-Noverón Nancy, Ruiz-de la Cruz Miguel, Díaz-Velásquez Clara Estela, Vidal-Millán Silvia, Álvarez-Gómez Rosa María, Sánchez-Correa Thalía Estefanía, Pech-Cervantes Claudio Hiram, Soria-Lucio José Antonio, Pérez-Castillo Areli, Salazar Ana María, Arriaga-Canon Cristian, Vaca-Paniagua Felipe, González-Arenas Aliesha, Ostrosky-Wegman Patricia, Mohar-Betancourt Alejandro, Herrera Luis A, Corona Teresa, Wegman-Ostrosky Tal |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: